APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Analysis Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Analysis Services Market Outlook and Growth Opportunities 2026

3 May 2026198 pages

Choose your research edition.

Industry ResearchPharmaceutical Analysis Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Analysis Services Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Analysis Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Analysis Services Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Pharmaceutical Analysis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Analysis Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Analysis Services market include Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical and Intertek Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Analysis Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Analysis Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Analysis Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Analysis Services market.

Pharmaceutical Analysis Services Segment by Company

Eurofins

WuXi AppTec

Pace Analytical Services

Catalent

LabCorp (Covance)

PPD

Element (Exova)

ALS Pharmaceutical

Intertek Group

SGS

Boston Analytical

DYNALABS

ADPEN Laboratories

ARL Bio Pharma

West Pharmaceutical

Microbac

Element (Analytical Lab Group)

Piramal Pharma Solutions

CTI

Weipu

PONY Medicine

Pharmaceutical Analysis Services Segment by Type

Raw Material Analysis

Microbiological Analysis

Drug Packaging Material Analysis

Biological Analysis and Testing

Other

Pharmaceutical Analysis Services Segment by Application

CRO

CMO and CDMO

Finished Drugs and Environment

Pharmaceutical Analysis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Analysis Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Analysis Services key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Analysis Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Analysis Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Analysis Services significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Analysis Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Analysis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Analysis Services industry.

Chapter 3: Detailed analysis of Pharmaceutical Analysis Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Analysis Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Analysis Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Analysis Services Industry Trends Table 2. Pharmaceutical Analysis Services Industry Drivers Table 3. Pharmaceutical Analysis Services Industry Opportunities and Challenges Table 4. Pharmaceutical Analysis Services Industry Restraints Table 5. Global Pharmaceutical Analysis Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Analysis Services Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Analysis Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Analysis Services Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Analysis Services Company, Product Type & Application Table 10. Global Pharmaceutical Analysis Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Analysis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Raw Material Analysis Table 15. Significant Companies of Microbiological Analysis Table 16. Significant Companies of Drug Packaging Material Analysis Table 17. Significant Companies of Biological Analysis and Testing Table 18. Significant Companies of Other Table 19. Global Pharmaceutical Analysis Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmaceutical Analysis Services Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Pharmaceutical Analysis Services Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Pharmaceutical Analysis Services Sales Value Share by Type (2021-2026) Table 23. Global Pharmaceutical Analysis Services Sales Value Share by Type (2027-2032) Table 24. Significant Companies of CRO Table 25. Significant Companies of CMO and CDMO Table 26. Significant Companies of Finished Drugs and Environment Table 27. Global Pharmaceutical Analysis Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Analysis Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Analysis Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Analysis Services Sales Value Share by Application (2021-2026) Table 31. Global Pharmaceutical Analysis Services Sales Value Share by Application (2027-2032) Table 32. Global Pharmaceutical Analysis Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Analysis Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Analysis Services Sales Value Share by Region (2021-2026) Table 35. Global Pharmaceutical Analysis Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Pharmaceutical Analysis Services Sales Value Share by Region (2027-2032) Table 37. Global Pharmaceutical Analysis Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Analysis Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Analysis Services Sales Value Market Share by Country (2021-2026) Table 40. Global Pharmaceutical Analysis Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Analysis Services Sales Value Market Share by Country (2027-2032) Table 42. Eurofins Company Information Table 43. Eurofins Business Overview Table 44. Eurofins Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eurofins Pharmaceutical Analysis Services Product Portfolio Table 46. Eurofins Recent Development Table 47. WuXi AppTec Company Information Table 48. WuXi AppTec Business Overview Table 49. WuXi AppTec Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. WuXi AppTec Pharmaceutical Analysis Services Product Portfolio Table 51. WuXi AppTec Recent Development Table 52. Pace Analytical Services Company Information Table 53. Pace Analytical Services Business Overview Table 54. Pace Analytical Services Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Pace Analytical Services Pharmaceutical Analysis Services Product Portfolio Table 56. Pace Analytical Services Recent Development Table 57. Catalent Company Information Table 58. Catalent Business Overview Table 59. Catalent Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Catalent Pharmaceutical Analysis Services Product Portfolio Table 61. Catalent Recent Development Table 62. LabCorp (Covance) Company Information Table 63. LabCorp (Covance) Business Overview Table 64. LabCorp (Covance) Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. LabCorp (Covance) Pharmaceutical Analysis Services Product Portfolio Table 66. LabCorp (Covance) Recent Development Table 67. PPD Company Information Table 68. PPD Business Overview Table 69. PPD Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. PPD Pharmaceutical Analysis Services Product Portfolio Table 71. PPD Recent Development Table 72. Element (Exova) Company Information Table 73. Element (Exova) Business Overview Table 74. Element (Exova) Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Element (Exova) Pharmaceutical Analysis Services Product Portfolio Table 76. Element (Exova) Recent Development Table 77. ALS Pharmaceutical Company Information Table 78. ALS Pharmaceutical Business Overview Table 79. ALS Pharmaceutical Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. ALS Pharmaceutical Pharmaceutical Analysis Services Product Portfolio Table 81. ALS Pharmaceutical Recent Development Table 82. Intertek Group Company Information Table 83. Intertek Group Business Overview Table 84. Intertek Group Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Intertek Group Pharmaceutical Analysis Services Product Portfolio Table 86. Intertek Group Recent Development Table 87. SGS Company Information Table 88. SGS Business Overview Table 89. SGS Pharmaceutical Analysis Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. SGS Pharmaceutical Analysis Services Product Portfolio Table 91. SGS Recent Development Table 92. Boston Analytical Company Information Table 93. Boston Analytical Business Overview Table 94. Boston Analytical Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Boston Analytical Pharmaceutical Analysis Services Product Portfolio Table 96. Boston Analytical Recent Development Table 97. DYNALABS Company Information Table 98. DYNALABS Business Overview Table 99. DYNALABS Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. DYNALABS Pharmaceutical Analysis Services Product Portfolio Table 101. DYNALABS Recent Development Table 102. ADPEN Laboratories Company Information Table 103. ADPEN Laboratories Business Overview Table 104. ADPEN Laboratories Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. ADPEN Laboratories Pharmaceutical Analysis Services Product Portfolio Table 106. ADPEN Laboratories Recent Development Table 107. ARL Bio Pharma Company Information Table 108. ARL Bio Pharma Business Overview Table 109. ARL Bio Pharma Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. ARL Bio Pharma Pharmaceutical Analysis Services Product Portfolio Table 111. ARL Bio Pharma Recent Development Table 112. West Pharmaceutical Company Information Table 113. West Pharmaceutical Business Overview Table 114. West Pharmaceutical Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. West Pharmaceutical Pharmaceutical Analysis Services Product Portfolio Table 116. West Pharmaceutical Recent Development Table 117. Microbac Company Information Table 118. Microbac Business Overview Table 119. Microbac Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Microbac Pharmaceutical Analysis Services Product Portfolio Table 121. Microbac Recent Development Table 122. Element (Analytical Lab Group) Company Information Table 123. Element (Analytical Lab Group) Business Overview Table 124. Element (Analytical Lab Group) Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Portfolio Table 126. Element (Analytical Lab Group) Recent Development Table 127. Piramal Pharma Solutions Company Information Table 128. Piramal Pharma Solutions Business Overview Table 129. Piramal Pharma Solutions Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Piramal Pharma Solutions Pharmaceutical Analysis Services Product Portfolio Table 131. Piramal Pharma Solutions Recent Development Table 132. CTI Company Information Table 133. CTI Business Overview Table 134. CTI Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. CTI Pharmaceutical Analysis Services Product Portfolio Table 136. CTI Recent Development Table 137. Weipu Company Information Table 138. Weipu Business Overview Table 139. Weipu Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Weipu Pharmaceutical Analysis Services Product Portfolio Table 141. Weipu Recent Development Table 142. PONY Medicine Company Information Table 143. PONY Medicine Business Overview Table 144. PONY Medicine Pharmaceutical Analysis Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. PONY Medicine Pharmaceutical Analysis Services Product Portfolio Table 146. PONY Medicine Recent Development Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Pharmaceutical Analysis Services Product Image Figure 2. Global Pharmaceutical Analysis Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Analysis Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Analysis Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Raw Material Analysis Image Figure 8. Microbiological Analysis Image Figure 9. Drug Packaging Material Analysis Image Figure 10. Biological Analysis and Testing Image Figure 11. Other Image Figure 12. Global Pharmaceutical Analysis Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmaceutical Analysis Services Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Analysis Services Sales Value Share by Type (2021-2032) Figure 15. CRO Image Figure 16. CMO and CDMO Image Figure 17. Finished Drugs and Environment Image Figure 18. Global Pharmaceutical Analysis Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Analysis Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Analysis Services Sales Value Share by Application (2021-2032) Figure 21. Global Pharmaceutical Analysis Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pharmaceutical Analysis Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Pharmaceutical Analysis Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Analysis Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Pharmaceutical Analysis Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Pharmaceutical Analysis Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Pharmaceutical Analysis Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Pharmaceutical Analysis Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Pharmaceutical Analysis Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Pharmaceutical Analysis Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Pharmaceutical Analysis Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Pharmaceutical Analysis Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Material Analysis
  • Microbiological Analysis
  • Drug Packaging Material Analysis
  • Biological Analysis and Testing
  • Other
Applications
  • CRO
  • CMO and CDMO
  • Finished Drugs and Environment
Companies covered
  • Eurofins
  • WuXi AppTec
  • Pace Analytical Services
  • Catalent
  • LabCorp (Covance)
  • PPD
  • Element (Exova)
  • ALS Pharmaceutical
  • Intertek Group
  • SGS
  • Boston Analytical
  • DYNALABS
  • ADPEN Laboratories
  • ARL Bio Pharma
  • West Pharmaceutical
  • Microbac
  • Element (Analytical Lab Group)
  • Piramal Pharma Solutions
  • CTI
  • Weipu
  • PONY Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Analysis Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Analysis Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Analysis Services Market Dynamics
  1. 2.1 Pharmaceutical Analysis Services Industry Trends
  2. 2.2 Pharmaceutical Analysis Services Industry Drivers
  3. 2.3 Pharmaceutical Analysis Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Analysis Services Industry Restraints
3 Pharmaceutical Analysis Services Market by Company
  1. 3.1 Global Pharmaceutical Analysis Services Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Analysis Services Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Analysis Services Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Analysis Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Analysis Services Company Product Type and Application
  6. 3.6 Global Pharmaceutical Analysis Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Analysis Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Analysis Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Analysis Services Market by Type
  1. 4.1 Pharmaceutical Analysis Services Type Introduction
  2. 4.1.1 Raw Material Analysis
  3. 4.1.2 Microbiological Analysis
  4. 4.1.3 Drug Packaging Material Analysis
  5. 4.1.4 Biological Analysis and Testing
  6. 4.1.5 Other
  7. 4.2 Global Pharmaceutical Analysis Services Sales Value by Type
  8. 4.2.1 Global Pharmaceutical Analysis Services Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmaceutical Analysis Services Sales Value by Type (2021-2032)
  10. 4.2.3 Global Pharmaceutical Analysis Services Sales Value Share by Type (2021-2032)
5 Pharmaceutical Analysis Services Market by Application
  1. 5.1 Pharmaceutical Analysis Services Application Introduction
  2. 5.1.1 CRO
  3. 5.1.2 CMO and CDMO
  4. 5.1.3 Finished Drugs and Environment
  5. 5.2 Global Pharmaceutical Analysis Services Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Analysis Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Analysis Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Analysis Services Sales Value Share by Application (2021-2032)
6 Pharmaceutical Analysis Services Regional Value Analysis
  1. 6.1 Global Pharmaceutical Analysis Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Analysis Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Analysis Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Analysis Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Analysis Services Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Analysis Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Analysis Services Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Analysis Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Analysis Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Analysis Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Analysis Services Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Analysis Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Analysis Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Analysis Services Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Analysis Services Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Analysis Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Analysis Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Analysis Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Analysis Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Analysis Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Analysis Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Analysis Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins
  2. 8.1.1 Eurofins Company Information
  3. 8.1.2 Eurofins Business Overview
  4. 8.1.3 Eurofins Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Pharmaceutical Analysis Services Product Portfolio
  6. 8.1.5 Eurofins Recent Developments
  7. 8.2 WuXi AppTec
  8. 8.2.1 WuXi AppTec Company Information
  9. 8.2.2 WuXi AppTec Business Overview
  10. 8.2.3 WuXi AppTec Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WuXi AppTec Pharmaceutical Analysis Services Product Portfolio
  12. 8.2.5 WuXi AppTec Recent Developments
  13. 8.3 Pace Analytical Services
  14. 8.3.1 Pace Analytical Services Company Information
  15. 8.3.2 Pace Analytical Services Business Overview
  16. 8.3.3 Pace Analytical Services Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pace Analytical Services Pharmaceutical Analysis Services Product Portfolio
  18. 8.3.5 Pace Analytical Services Recent Developments
  19. 8.4 Catalent
  20. 8.4.1 Catalent Company Information
  21. 8.4.2 Catalent Business Overview
  22. 8.4.3 Catalent Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Catalent Pharmaceutical Analysis Services Product Portfolio
  24. 8.4.5 Catalent Recent Developments
  25. 8.5 LabCorp (Covance)
  26. 8.5.1 LabCorp (Covance) Company Information
  27. 8.5.2 LabCorp (Covance) Business Overview
  28. 8.5.3 LabCorp (Covance) Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 LabCorp (Covance) Pharmaceutical Analysis Services Product Portfolio
  30. 8.5.5 LabCorp (Covance) Recent Developments
  31. 8.6 PPD
  32. 8.6.1 PPD Company Information
  33. 8.6.2 PPD Business Overview
  34. 8.6.3 PPD Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PPD Pharmaceutical Analysis Services Product Portfolio
  36. 8.6.5 PPD Recent Developments
  37. 8.7 Element (Exova)
  38. 8.7.1 Element (Exova) Company Information
  39. 8.7.2 Element (Exova) Business Overview
  40. 8.7.3 Element (Exova) Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Element (Exova) Pharmaceutical Analysis Services Product Portfolio
  42. 8.7.5 Element (Exova) Recent Developments
  43. 8.8 ALS Pharmaceutical
  44. 8.8.1 ALS Pharmaceutical Company Information
  45. 8.8.2 ALS Pharmaceutical Business Overview
  46. 8.8.3 ALS Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ALS Pharmaceutical Pharmaceutical Analysis Services Product Portfolio
  48. 8.8.5 ALS Pharmaceutical Recent Developments
  49. 8.9 Intertek Group
  50. 8.9.1 Intertek Group Company Information
  51. 8.9.2 Intertek Group Business Overview
  52. 8.9.3 Intertek Group Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intertek Group Pharmaceutical Analysis Services Product Portfolio
  54. 8.9.5 Intertek Group Recent Developments
  55. 8.10 SGS
  56. 8.10.1 SGS Company Information
  57. 8.10.2 SGS Business Overview
  58. 8.10.3 SGS Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SGS Pharmaceutical Analysis Services Product Portfolio
  60. 8.10.5 SGS Recent Developments
  61. 8.11 Boston Analytical
  62. 8.11.1 Boston Analytical Company Information
  63. 8.11.2 Boston Analytical Business Overview
  64. 8.11.3 Boston Analytical Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boston Analytical Pharmaceutical Analysis Services Product Portfolio
  66. 8.11.5 Boston Analytical Recent Developments
  67. 8.12 DYNALABS
  68. 8.12.1 DYNALABS Company Information
  69. 8.12.2 DYNALABS Business Overview
  70. 8.12.3 DYNALABS Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DYNALABS Pharmaceutical Analysis Services Product Portfolio
  72. 8.12.5 DYNALABS Recent Developments
  73. 8.13 ADPEN Laboratories
  74. 8.13.1 ADPEN Laboratories Company Information
  75. 8.13.2 ADPEN Laboratories Business Overview
  76. 8.13.3 ADPEN Laboratories Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ADPEN Laboratories Pharmaceutical Analysis Services Product Portfolio
  78. 8.13.5 ADPEN Laboratories Recent Developments
  79. 8.14 ARL Bio Pharma
  80. 8.14.1 ARL Bio Pharma Company Information
  81. 8.14.2 ARL Bio Pharma Business Overview
  82. 8.14.3 ARL Bio Pharma Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ARL Bio Pharma Pharmaceutical Analysis Services Product Portfolio
  84. 8.14.5 ARL Bio Pharma Recent Developments
  85. 8.15 West Pharmaceutical
  86. 8.15.1 West Pharmaceutical Company Information
  87. 8.15.2 West Pharmaceutical Business Overview
  88. 8.15.3 West Pharmaceutical Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 West Pharmaceutical Pharmaceutical Analysis Services Product Portfolio
  90. 8.15.5 West Pharmaceutical Recent Developments
  91. 8.16 Microbac
  92. 8.16.1 Microbac Company Information
  93. 8.16.2 Microbac Business Overview
  94. 8.16.3 Microbac Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Microbac Pharmaceutical Analysis Services Product Portfolio
  96. 8.16.5 Microbac Recent Developments
  97. 8.17 Element (Analytical Lab Group)
  98. 8.17.1 Element (Analytical Lab Group) Company Information
  99. 8.17.2 Element (Analytical Lab Group) Business Overview
  100. 8.17.3 Element (Analytical Lab Group) Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Portfolio
  102. 8.17.5 Element (Analytical Lab Group) Recent Developments
  103. 8.18 Piramal Pharma Solutions
  104. 8.18.1 Piramal Pharma Solutions Company Information
  105. 8.18.2 Piramal Pharma Solutions Business Overview
  106. 8.18.3 Piramal Pharma Solutions Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Piramal Pharma Solutions Pharmaceutical Analysis Services Product Portfolio
  108. 8.18.5 Piramal Pharma Solutions Recent Developments
  109. 8.19 CTI
  110. 8.19.1 CTI Company Information
  111. 8.19.2 CTI Business Overview
  112. 8.19.3 CTI Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 CTI Pharmaceutical Analysis Services Product Portfolio
  114. 8.19.5 CTI Recent Developments
  115. 8.20 Weipu
  116. 8.20.1 Weipu Company Information
  117. 8.20.2 Weipu Business Overview
  118. 8.20.3 Weipu Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Weipu Pharmaceutical Analysis Services Product Portfolio
  120. 8.20.5 Weipu Recent Developments
  121. 8.21 PONY Medicine
  122. 8.21.1 PONY Medicine Company Information
  123. 8.21.2 PONY Medicine Business Overview
  124. 8.21.3 PONY Medicine Pharmaceutical Analysis Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 PONY Medicine Pharmaceutical Analysis Services Product Portfolio
  126. 8.21.5 PONY Medicine Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst